找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Dipeptidyl Aminopeptidases in Health and Disease; Nathan Back,Irun R. Cohen,Rodolfo Paoletti Book 2003 The Editor(s) (if applicable) and T

[復(fù)制鏈接]
樓主: indulge
41#
發(fā)表于 2025-3-28 16:43:26 | 只看該作者
0065-2598 nopeptidases exert a potent modulatory role at an interface between immune mechanisms, metabolic responses and neuroendocrine pathways. Experimental models and clinical studies addressing the role of these enzymes and the effect of specific inhibitors pave the way to novel therapeutic concepts in im
42#
發(fā)表于 2025-3-28 22:50:16 | 只看該作者
43#
發(fā)表于 2025-3-29 02:29:01 | 只看該作者
44#
發(fā)表于 2025-3-29 04:10:43 | 只看該作者
Dipeptidyl Peptidase IV Gene Familyotential role for DP8 and DP9 in liver disease, T cell activation and immune function. The role of the two novel enzymes DP8 and DP9 and the other non-enzyme member DPL2 in human disease will be the focus of further studies.
45#
發(fā)表于 2025-3-29 10:07:09 | 只看該作者
Isolation and Characterization of Attractin-2 insertion of the isoforms 1, 2, 4 and 5 and questioned the predicted Ser 26 as an active site residue..We could not find differences between DP IV and attractin with respect to the specificity of inhibitors or substrates. Attractin is also capable to release dipeptides from higher molecular substrates such as neuropeptide Y.
46#
發(fā)表于 2025-3-29 13:26:57 | 只看該作者
Specific Sports-Related Injuriesthink that DPP IV inhibitors have only little or no side effects on chemokines. Such side effects would be the prolongation or increase of inflammatory responses which have, to our knowledge, not yet been reported after in vivo applications in humans.
47#
發(fā)表于 2025-3-29 19:12:25 | 只看該作者
48#
發(fā)表于 2025-3-29 20:08:34 | 只看該作者
49#
發(fā)表于 2025-3-30 00:35:04 | 只看該作者
Structure-Function Relationship of DPP IV: Insights into its Dimerisation and Gelatinase Activity
50#
發(fā)表于 2025-3-30 06:00:52 | 只看該作者
Exploration of the Active Site of Dipeptidyl Peptidase IV From
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 11:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
游戏| 平凉市| 富民县| 江孜县| 惠水县| 肃北| 杭州市| 曲阜市| 长沙市| 台州市| 突泉县| 萨嘎县| 青冈县| 谢通门县| 民丰县| 济阳县| 陇川县| 阿尔山市| 商都县| 广州市| 斗六市| 临沭县| 岐山县| 石嘴山市| 胶州市| 衢州市| 江津市| 屏东市| 定州市| 怀宁县| 隆子县| 玛多县| 呼玛县| 卓尼县| 六安市| 龙井市| 昌都县| 榆树市| 金门县| 绵竹市| 观塘区|